A team of researchers from the USA and Cameroon has developed a non-invasive device that can detect malaria without requiring a single drop of blood. The device, called Cytophone, uses photoacoustic flow cytometry to rapidly identify malaria-infected red blood cells. Initial testing in 30 Cameroonian adults diagnosed with uncomplicated malaria showed promising results, with 95% sensitivity at the first visit and 90% sensitivity during the follow-up period.
Forecast for 6 months: The Cytophone device is expected to undergo further clinical trials and testing in various regions, including Africa and Southeast Asia, where malaria is prevalent. Regulatory approvals and partnerships with healthcare organizations are likely to be secured within the next six months.
Forecast for 1 year: The Cytophone device is expected to be commercially available in select countries, with a focus on malaria-endemic areas. The device’s cost-effectiveness and ease of use are likely to make it a popular choice among healthcare professionals, leading to widespread adoption.
Forecast for 5 years: The Cytophone device is expected to become a standard tool in malaria diagnosis, with widespread adoption in both developed and developing countries. The device’s technology is also likely to be adapted for use in detecting other diseases, such as cancer and cardiovascular disease.
Forecast for 10 years: The Cytophone device is expected to have a significant impact on global health, leading to a reduction in malaria-related deaths and a significant improvement in healthcare outcomes. The device’s technology is also likely to be integrated into wearable devices and mobile health platforms, enabling real-time monitoring and early detection of diseases.
